Limia A, Jiménez M L, Alarcón T, López-Brea M
Department of Microbiology, Hospital Universitario de la Princesa, Madrid, Spain.
Eur J Clin Microbiol Infect Dis. 1999 Jun;18(6):440-4. doi: 10.1007/s100960050315.
Susceptibility to 17 antibiotics was studied in 180 strains of the Streptococcus milleri group (88 Streptococcus anginosus, 63 Streptococcus constellatus, and 29 Streptococcus intermedius) isolated over a 5-year period. Minimum inhibitory concentrations of penicillin were in the intermediate range for 5.6% of the strains. Resistance to erythromycin and clindamycin was found in 17.1% and 16.6% of the isolates, respectively. A steady increase in the susceptibility to ciprofloxacin was observed over the study period. Imipenem was the most active beta-lactam agent tested. Glycopeptide antibiotics showed excellent activity. Only slight differences between the three species were found in terms of antibiotic susceptibility. Intermediate resistance to penicillin is appearing among the Streptococcus milleri group in our area; consequently, care must be taken when choosing a macrolide for the management of infections caused by these microorganisms.
对在5年期间分离出的180株米勒链球菌组菌株(88株咽峡炎链球菌、63株星座链球菌和29株中间链球菌)进行了17种抗生素的敏感性研究。5.6%的菌株青霉素最低抑菌浓度处于中间范围。分别有17.1%和16.6%的分离株对红霉素和克林霉素耐药。在研究期间观察到对环丙沙星的敏感性稳步增加。亚胺培南是所测试的活性最强的β-内酰胺类药物。糖肽类抗生素显示出优异的活性。在抗生素敏感性方面,这三个菌种之间仅发现细微差异。在我们地区的米勒链球菌组中出现了对青霉素的中度耐药;因此,在选择大环内酯类药物治疗这些微生物引起的感染时必须谨慎。